Vitamin E and drug metabolism

Biochemical and Biophysical Research Communications

Volumn 305, Issue 3, 2003, Pages 737-740

  Brigelius Flohé, Regina ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Cytochrome P450; Drug; Interaction; Metabolism; Pregnane X receptor; Tocopherol; Tocotrienol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; PREGNANE X RECEPTOR; TOCOPHEROL;

ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME SUBSTRATE; FATTY ACID OMEGA OXIDATION; FATTY ACID OXIDATION; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPORTER GENE; VITAMIN METABOLISM;

EID: 0038578413     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00811-8     Document Type: Article

References (37)

1. Simon E.J. The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of α-tocopherol. J. Biol. Chem. 221:1956;807-817.
2. Pope S.A.S., Green H., Clayton P.T., Goss-Sampson M.A., Muller D.P.R. The possible use of urinary α-tocopheronolactone as a biomarker of oxidative stress. Free Radic. Res. 36(Suppl. 1):2002;82-83.
3. Pope S.A., Burtin G.E., Clayton P.T., Madge D.J., Muller D.P. Synthesis and analysis of conjugates of the major vitamin E metabolite, alpha-CEHC. Free Radic. Biol. Med. 33:2002;807-817.
4. ′ -carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am. J. Clin. Nutr. 62:1995;1527S-1534S.
5. Wechter J.W., Kantoci D., Murray E.D., D'Amico D.C., Jung M.E., Wang W.-H. A new endogenous natriuretic factor: LLU-α Proc. Natl. Acad. Sci. USA. 93:1993;6002-6007.
6. Chiku S., Hamamura K., Nakamura T. Novel urinary metabolite of d-delta-tocopherol in rats. J. Lipid Res. 25:1984;40-48.
7. Lodge J.K., Ridlington J., Leonard S., Vaule H., Traber M.G. Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids. 36:2001;43-48.
8. ′ -carboxyethyl)-6-hydroxychroman in human serum Anal. Biochem. 275:1999;254-259.
9. Galli F., Lee R., Dunster C., Kelly F.J. Gas chromatography mass spectrometry analysis of carboxyethyl-hydroxychroman metabolites of alpha- and gamma-tocopherol in human plasma. Free Radic. Biol. Med. 32:2002;333-340.
10. Birringer M., Pfluger P., Kluth D., Landes N., Brigelius-Flohé R. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J. Nutr. 132:2002;3113-3118.
11. 450 omega-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. J. Biol. Chem. 277:2002;25290-25296.
12. Parker R.S., Sontag T.J., Swanson J.E. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem. Biophys. Res. Commun. 277:2000;531-534.
13. ′ -carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol J. Nutr. 132:2002;961-966.
14. Birringer M., Drogan D., Brigelius-Flohé R. Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation. Free Radic. Biol. Med. 31:2001;226-232.
15. Brigelius-Flohé R., Kluth D., Landes N., Pfluger P., Birringer M. Mechanisms of vitamin E metabolism. Packer L., Traber M.G., Kraemer K., Frei B. The Antioxidant Vitamins C and E. 2002;171-179 AOCS Press, Champaign, IL, USA.
16. Kikuta Y., Miyauchi Y., Kusunose E., Kusunose M. Expression and molecular cloning of human liver leukotriene B4 omega-hydroxylase (CYP4F2) gene. DNA Cell. Biol. 18:1999;723-730.
17. Hardwick J.P., Chen L. Something completely different? Hum. Exp. Toxicol. 15:1996;543-544.
18. Kawashima H., Kusunose E., Thompson C.M., Strobel H.W. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch. Biochem. Biophys. 347:1997;148-154.
19. Zhang X., Hardwick J.P. Regulation of CYP4F2 leukotriene B4 omega-hydroxylase by retinoic acids in HepG2 cells. Biochem. Biophys. Res. Commun. 279:2000;864-871.
20. Cholerton S., Daly A.K., Idle J.R. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol. Sci. 13:1992;434-439.
21. Gibson G.G., Plant N.J., Swales K.E., Ayrton A., El-Sankary W. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica. 32:2002;165-206.
22. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., Perlmann T., Lehmann J.M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:1998;73-82.
23. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102:1998;1016-1023.
24. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., Willson T.M., Kliewer S.A., Redinbo M.R. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292:2001;2329-2333.
25. Landes N., Pfluger P., Kluth D., Birringer M., Rühl R., Böl G.-F., Glatt H.R., Brigelius-Flohé R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65:2003;269-273.
26. Carpenter M.P. Vitamin E and microsomal drug hydroxylations. Ann. N.Y. Acad. Sci. 203:1972;81-92.
27. Mikus G., Bochner F., Eichelbaum M., Horak P., Somogyi A.A., Spector S. Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism. J. Pharmacol. Exp. Ther. 268:1994;546-551.
28. Gairola C., Chen L.H. Effect of dietary vitamin E on the aryl hydrocarbon hydroxylase activity of various tissues in rat. Int. J. Vitam. Nutr. Res. 52:1982;398-401.
29. Cassand P., Decoudu S., Leveque F., Daubeze M., Narbonne J.F. Effect of vitamin E dietary intake on in vitro activation of aflatoxin B1. Mutat. Res. 319:1993;309-316.
30. Rowe L., Wills E.D. The effect of dietary lipids and vitamin E on lipid peroxide formation, cytochrome P-450 and oxidative demethylation in the endoplasmic reticulum. Biochem. Pharmacol. 25:1976;175-179.
31. Murray M. In vitro and in vivo studies of the effect of vitamin E on microsomal cytochrome P450 in rat liver. Biochem. Pharmacol. 42:1991;2107-2114.
32. Shimada H., Furuno H., Hirai K., Koyama J., Ariyama J., Simamura E. Paraquat detoxicative system in the mouse liver postmitochondrial fraction. Arch. Biochem. Biophys. 402:2002;149-157.
33. Fischer A., Pallauf J., Rimbach G. Selenium- and vitamin E-dependent gene expression in rats: analysis of differentially expressed mRNAs. Methods Enzymol. 347:2002;267-276.
34. Roy S., Lado B.H., Khanna S., Sen C.K. Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 530:2002;17-23.
35. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 32:2002;451-478.
36. Moore L.B., Goodwin B., Jones S.A., Wisely G.B., Serabjit-Singh C.J., Willson T.M., Collins J.L., Kliewer S.A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA. 97:2000;7500-7502.
37. Wentworth J.M., Agostini M., Love J., Schwabe J.W., Chatterjee V.K. St John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol. 166:2000;R11-R16.